Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 23
  • 1
  • 2
  • »
In January 2022, ACCC co-sponsored Health Care Value Week, a series of virtual events with top Administration officials from CMS to support the advancement of value-based care. By highlighting the success stories of value-based payment models and addressing the need to further eliminate barriers to care for marginalized groups, the event discussed next steps in providing more equitable, …
In the absence of a successor to the Oncology Care Model (OCM), the future looks bleak.
The crowds may have left, but last week’s ACCC 45th Annual Meeting & Cancer Center Business Summit held March 20-22, in Washington, D.C., leaves lingering food for thought regarding how cancer programs and practices can adapt and grow by addressing today’s (and tomorrow’s) most challenging healthcare delivery issues. Over three days, sessions explored how our healthcare and our cancer care delivery …
At the ACCC 45th Annual Meeting and Cancer Center Business Summit, I announced my 2019-2020 President’s Theme: Collaborate. Educate. Compensate: A Prescription for Sustainable Care Delivery.
Mercy Cancer Care responded to OP-35 was by developing an internal report that predicted the metrics for one of its larger oncology practices.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
The Centers for Medicare & Medicaid Services (CMS) released the final Medicare payment rules for calendar year (CY) 2020 in tandem this year on Nov. 1, 2019. Subsequently, on Nov. 15, the agency finalized hospital price transparency proposals originally included in the proposed CY 2020 Outpatient Prospective Payment System (OPPS) with the release of the 2020 Price Transparency Requirements for …
From January 24 to 28, 2022, ACCC co-sponsored Health Care Value Week—a series of virtual events supporting the advancement of value-based care.
On August 30, the U.S. Food and Drug Administration (FDA) approved the first CAR Chimeric Antigen Receptor (CAR) T-cell therapy, tisagenlecleucel (Kymriah). With this approval of the first cancer gene therapy in the U.S., immuno-oncology took a historic step forward. Later that same day, in a press release titled, “Innovative Treatments Call for Innovative Payment Models and Arrangement,” the Centers …
Healthcare Futurist Joe Flower opened the #AMCCBS this morning with a quote that may be unexpected from a predictor of scenarios to come: “We don’t need new sights; we need new eyes.” Rather than project a Jetsons-inspired vision of healthcare powered by AI and advanced robotics, Flower began by grounding attendees at the 45th ACCC Annual Meeting & Cancer Center Business Summit in the facts and …
To prevent implementation of the model, ACCC joined with the Global Colon Cancer Association, the National Infusion Center Association, and the Pharmaceutical Research and Manufacturers of America to file a lawsuit against the U.S. Department of Health and Human Services, seeking an immediate injunction to prevent the implementation of the MFN model.
On Dec. 2, 2020, the Centers for Medicare & Medicaid Services (CMS) issued the final rules for the Hospital Outpatient Prospective Payment System (HOPPS or OPPS) for CY 2021.
At the March 20 Radiation Oncology Pre-Conference to the ACCC 45th Annual Meeting & Cancer Center Business Summit the message was clear: Change is coming, and it’s coming in bundles. Presenter David C. Beyer, MD, FACR, FACRO, FASTRO, Medical Director, Cancer Centers of Northern Arizona Healthcare, crystalized the conundrum: While change is central to the specialty and the practice of …
The February decision by the Center for Medicare and Medicaid Innovation (CMMI) to build its first specialty care model around oncology is an important indication of the agency’s focus on how to contain costs in cancer care.
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
Friday, Nov. 1 was a busy day for the Centers for Medicare & Medicaid Services (CMS) and its Center for the Medicare and Medicaid Innovation (CMMI). CMS released the final calendar year (CY) 2020 Hospital Outpatient Prospective System and Physician Fee Schedule final rules. Later that afternoon, CMMI posted an “informal” Request for Information on a proposal for the next iteration of an …
From transitioning to value-based care to effectively onboarding new members of the care team, the ACCC Radiation Oncology Pre-Conference on March 5 covered current and near-term challenges facing the field of radiation oncology. The half-day multi-session program was held in conjunction with the ACCC 46th Annual Meeting & Cancer Center Business Summit in Washington, D.C. The pre-conference kicked …
The oncology community has experienced dramatic marketplace consolidation over the last several years. For some physician practices this consolidation has given rise to new partnerships with hospitals and health systems; while for others it has meant outright purchase by a hospital or health system. Still, many physician practices have embraced the transition from fee-for-service to value-based …
On July 10, 2019, the Centers for Medicare & Medicaid Services (CMS) revealed new details of a proposed bundled payment model for radiation oncology services (“RO Model”).
As the United States healthcare system moves to value-based and bundled payments under alternative payment models, it is now more important than ever for cancer programs and practices to quantitatively and qualitatively measure to show the value that supportive cancer care services bring to patients.
    Displaying results 1 - 20 of 23
  • 1
  • 2
  • »